ログインで組織・契約価格をご覧ください。
サイズを選択してください
この商品について
実験式（ヒル表記法）:
C17H20N4O6
CAS番号:
分子量:
376.36
UNSPSC Code:
41116107
NACRES:
NA.24
PubChem Substance ID:
MDL number:
Beilstein/REAXYS Number:
97825
製品名
(−)-リボフラビン, United States Pharmacopeia (USP) Reference Standard
InChI
1S/C17H20N4O6/c1-7-3-9-10(4-8(7)2)21(5-11(23)14(25)12(24)6-22)15-13(18-9)16(26)20-17(27)19-15/h3-4,11-12,14,22-25H,5-6H2,1-2H3,(H,20,26,27)/t11-,12+,14-/m0/s1
SMILES string
CC1=C(C)C=C(N(C[C@H](O)[C@@H]([C@H](O)CO)O)C(C2=N3)=NC(NC2=O)=O)C3=C1
InChI key
AUNGANRZJHBGPY-SCRDCRAPSA-N
grade
pharmaceutical primary standard
API family
riboflavin
manufacturer/tradename
USP
mp
290 °C (dec.) (lit.)
application(s)
pharmaceutical (small molecule)
format
neat
storage temp.
2-8°C
類似した製品をお探しですか？ 訪問 製品比較ガイド
General description
この製品は薬局方標準品です。発行元の薬局方により製造・供給されています。MSDSを含む製品情報などの詳しい情報は、発行元の薬局方のウェブサイトよりご確認ください。
Analysis Note
These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
Application
Riboflavin USP reference standard for use in specified quality tests and assays.
Also used to prepare standard, and standard stock Riboflavin solution for assay, identification, and performance test according to the given below monographs and general chapters of United States Pharmacopeia (USP):
Also used to prepare standard, and standard stock Riboflavin solution for assay, identification, and performance test according to the given below monographs and general chapters of United States Pharmacopeia (USP):
- Riboflavin
- Riboflavin Tablets
- Water-Soluble Vitamins Preparation
- 〈481〉 Riboflavin Assay
Other Notes
Sales restrictions may apply.
保管分類
11 - Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Riboflavin Tablets
United States Pharmacopeia, 41(6), 3870-3870 (2017)
Water-Soluble Vitamins Preparation
United States Pharmacopeia, 45(5) (2021)
?481? Riboflavin Assay
United States Pharmacopeia, 41(6), 6735-6735 (2017)
Riboflavin
United States Pharmacopeia, 30(3), 3869-3869 (2013)
Nacim Bouheraoua et al.
Investigative ophthalmology & visual science, 55(11), 7601-7609 (2014-10-30)
We compared the efficacy and early morphological changes in the cornea following conventional (C-CXL), transepithelial by iontophoresis (I-CXL), and accelerated (A-CXL) collagen cross-linking in keratoconus. A total of 45 eyes of 45 patients with progressive keratoconus who underwent corneal collagen
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）